The University of Chicago Header Logo

Connection

Janardan Khandekar to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Janardan Khandekar has written about Dose-Response Relationship, Drug.
Janardan Khandekar
Connection Strength
0.025
Dose-Response Relationship, Drug
  1. Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma. Cancer Invest. 2007 Aug; 25(5):366-71.
    View in: PubMed
    Score: 0.013
  2. Studies of amygdalin (laetrile) toxicity in rodents. JAMA. 1979 Jul 13; 242(2):169-71.
    View in: PubMed
    Score: 0.007
  3. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
    View in: PubMed
    Score: 0.003
  4. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res. 1985 Feb; 45(2):863-71.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.